Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-11

Clinical Trial Update: DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for DEXTENZA in treating pain and inflammation after glaucoma-related surgical procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)

Snippet

Sponsor: Brian Jerkins, MD | Conditions: Glaucoma Following Surgery | Phase 4 | Status: UNKNOWN